Eli Lilly and Company & Israel

Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.

Israel: Israel>>>'s attack on Iran>>> in late February initiated the war that has significantly impacted oil prices and global markets.

Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.

Israel: Israel is seeking talks with Lebanon, contributing to easing worries over the Middle East conflict and positively influencing market sentiment.

Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.

Israel: Israel is a key player in the regional conflict, having launched initial airstrikes on Iran and continuing its campaign against Hezbollah in Lebanon. Its security concerns, particularly regarding Iran's nuclear program and ballistic missiles, are central to the broader peace efforts.

Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.

Israel: Israel has conducted military operations in Lebanon against Hezbollah, which Iran demands cease as part of any peace deal. Israel has also experienced drone attacks from Hezbollah.

Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.

Israel: Tensions involving Israel and the U.S.-Israeli war could lead to renewed spikes in energy prices, posing a risk to the market.